SGMT
Price:
$6.35
Market Cap:
$196.86M
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
Industry
Biotechnology
IPO Date
2023-07-17
Stock Exchange
NASDAQ
Ticker
SGMT
According to Sagimet Biosciences Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -3.57. This represents a change of 2.75% compared to the average of -3.47 of the last 4 quarters.
The mean historical PE Ratio of Sagimet Biosciences Inc. over the last ten years is -14.77. The current -3.57 PE Ratio has changed 2.32% with respect to the historical average. Over the past ten years (40 quarters), SGMT's PE Ratio was at its highest in in the March 2025 quarter at -1.44. The PE Ratio was at its lowest in in the March 2020 quarter at -22.20.
Average
-14.77
Median
-13.03
Minimum
-31.11
Maximum
-3.10
Discovering the peaks and valleys of Sagimet Biosciences Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 25.43%
Maximum Annual PE Ratio = -3.10
Minimum Annual Increase = -69.49%
Minimum Annual PE Ratio = -31.11
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -3.10 | -12.48% |
| 2023 | -3.54 | -69.49% |
| 2022 | -11.60 | -19.86% |
| 2021 | -14.47 | -53.48% |
| 2020 | -31.11 | 25.43% |
The current PE Ratio of Sagimet Biosciences Inc. (SGMT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-6.08
5-year avg
-12.76
10-year avg
-14.77
Sagimet Biosciences Inc.’s PE Ratio is greater than Arcturus Therapeutics Holdings Inc. (-3.71), greater than Humacyte, Inc. (-10.58), greater than Assembly Biosciences, Inc. (-6.93), greater than Zura Bio Limited (-5.48), less than Voyager Therapeutics, Inc. (-2.02), greater than Entrada Therapeutics, Inc. (-4.07), greater than Foghorn Therapeutics Inc. (-3.83), greater than Immuneering Corporation (-3.87), greater than Achieve Life Sciences, Inc. (-4.66), less than Atea Pharmaceuticals, Inc. (-1.90),
| Company | PE Ratio | Market cap |
|---|---|---|
| -3.71 | $185.27M | |
| -10.58 | $185.66M | |
| -6.93 | $303.71M | |
| -5.48 | $252.94M | |
| -2.02 | $241.84M | |
| -4.07 | $388.31M | |
| -3.83 | $258.99M | |
| -3.87 | $242.86M | |
| -4.66 | $254.41M | |
| -1.90 | $241.42M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sagimet Biosciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sagimet Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Sagimet Biosciences Inc.'s PE Ratio?
How is the PE Ratio calculated for Sagimet Biosciences Inc. (SGMT)?
What is the highest PE Ratio for Sagimet Biosciences Inc. (SGMT)?
What is the 3-year average PE Ratio for Sagimet Biosciences Inc. (SGMT)?
What is the 5-year average PE Ratio for Sagimet Biosciences Inc. (SGMT)?
How does the current PE Ratio for Sagimet Biosciences Inc. (SGMT) compare to its historical average?